publication venue for
- Infection With Chlamydia trachomatis Increases the Risk of High-grade Anal Intraepithelial Neoplasia in People Living With Human Immunodeficiency Virus. 2161-2167. 2020
- An Unusual Cause of Chronic Back Pain in a Migrant From Western Sahara.. 2131-2134. 2019
- Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ¿50 Years: Final 96-Week Results of the NEAT022 Study. 597-606. 2019
- Immediate vs. Deferred Switching from a Boosted Protease Inhibitor (PI/r) Based Regimen to a Dolutegravir (DTG) Based Regimen in Virologically Suppressed Patients with High Cardiovascular Risk or Age ¿50 years: Final 96 Weeks Results of NEAT 022 study.. 1-7. 2018
- Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression. 1191-1197. 2017
- Analysis of Non-AIDS-Defining Events in HIV Controllers. 1304-1309. 2016
- Trasmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe. 655-664. 2016
- Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. 1262-1268. 2015
- Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.. 1262-1268. 2015
- Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. 1-12. 2015
- Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical Trial. 1-10. 2014
- Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.. 1312-1321. 2014
- Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study.. 1579-1587. 2014
- Once-a-day highly active antiretroviral therapy: a systematic review. 1186-1190. 2013
- Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. 901-904. 2013
- The incidence of AIDS-defining illnesses at a current CD4 count ¿ 200 cells/¿L in the post-combination antiretroviral therapy era. 1038-1047. 2013
- Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.. 1-4. 2012
- Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. . 1364-1372. 2012
- Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006. 1467-1470. 2009
- Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).. 892-900. 2009
- ¿Asymptomatic bacteriuria in women with diabetes: influence of metabolic control?. . 1732-1733. 2008
- Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results. 1484-1492. 2007
- Lack of efficacy of voriconazole therapy in patients with pulmonary fungus balls. . 1706-1707. 2005
- Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy using therapeutic drug monitoring. . 1648-1653. 2005
- Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.. 670-676. 2005
- Single-slice computed tomography scan and skinfold anthropometry to evaluate facial lipoatrophy in HIV-infected patients. 1848-1851. 2004
- Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. 286-292. 2003
- Evaluation of the immunochromatographic Binax Now assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. 286-292. 2003
- Good interpretation of a diagnostic test (Reply). 1144-1145. 2003
- A Janeway lesion and an Osler node. 63-149. 2001